Apeloa Pharmaceutical Co Ltd (000739) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.38x

Apeloa Pharmaceutical Co Ltd (000739) has a Cash Flow Reinvestment Rate of 0.38x as of December 2025, reinvesting CN¥168.67 Million (capex CN¥166.73 Million plus investments CN¥1.94 Million) from operating cash flow of CN¥446.18 Million. Explore reinvestment intensity of Apeloa Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.38x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥168.67 Million
Capex + Investments

Operating Cash Flow

CN¥446.18 Million
CNY

Capital Expenditures

CN¥166.73 Million
CNY

Apeloa Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1998–2025)

Historical reinvestment intensity for Apeloa Pharmaceutical Co Ltd across 26 annual periods. Also explore 000739 asset base for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Apeloa Pharmaceutical Co Ltd (1998–2025)

Year-by-year capital reinvestment analysis for Apeloa Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 000739 company net worth.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 0.35x CN¥435.36 Million CN¥1.23 Billion CN¥386.21 Million ▼ -17.0%
2024 0.43x CN¥515.11 Million CN¥1.21 Billion CN¥460.75 Million ▼ -66.4%
2023 1.27x CN¥1.31 Billion CN¥1.03 Billion CN¥630.47 Million ▲ +226.5%
2022 0.39x CN¥514.89 Million CN¥1.33 Billion CN¥509.11 Million ▼ -70.1%
2021 1.30x CN¥794.48 Million CN¥611.75 Million CN¥701.92 Million ▲ +96.6%
2020 0.66x CN¥699.74 Million CN¥1.06 Billion CN¥317.12 Million ▲ +130.1%
2019 0.29x CN¥390.45 Million CN¥1.36 Billion CN¥31.85 Million ▲ +30.6%
2018 0.22x CN¥183.02 Million CN¥832.69 Million CN¥81.62 Million ▼ -82.6%
2017 1.26x CN¥264.82 Million CN¥209.80 Million CN¥163.42 Million ▼ -63.9%
2016 3.50x CN¥631.12 Million CN¥180.42 Million CN¥331.35 Million ▲ +240.8%
2015 1.03x CN¥452.75 Million CN¥441.16 Million CN¥452.06 Million ▲ +49.4%
2014 0.69x CN¥540.22 Million CN¥786.64 Million CN¥540.22 Million ▼ -74.1%
2013 2.65x CN¥505.01 Million CN¥190.45 Million CN¥505.01 Million ▲ +162.3%
2012 1.01x CN¥339.59 Million CN¥335.90 Million CN¥339.59 Million ▲ +41.4%
2011 0.71x CN¥289.21 Million CN¥404.62 Million CN¥289.21 Million ▼ -38.1%
2010 1.15x CN¥139.81 Million CN¥121.05 Million CN¥139.81 Million ▲ +156.9%
2009 0.45x CN¥93.66 Million CN¥208.30 Million CN¥93.66 Million ▼ -87.8%
2008 3.69x CN¥349.04 Million CN¥94.57 Million CN¥349.04 Million ▲ +455.7%
2007 0.66x CN¥115.70 Million CN¥174.20 Million CN¥115.70 Million ▲ +96.7%
2006 0.34x CN¥53.84 Million CN¥159.43 Million CN¥53.84 Million ▼ -75.7%
2005 1.39x CN¥121.65 Million CN¥87.40 Million CN¥121.65 Million ▼ -40.4%
2004 2.34x CN¥111.07 Million CN¥47.54 Million CN¥111.07 Million ▲ +179.4%
2003 0.84x CN¥88.09 Million CN¥105.36 Million CN¥88.09 Million ▼ -95.0%
2002 16.78x CN¥47.23 Million CN¥2.81 Million CN¥47.23 Million ▲ +3595.5%
2000 0.45x CN¥3.22 Million CN¥7.08 Million CN¥3.22 Million ▼ -16.8%
1998 0.55x CN¥16.43 Million CN¥30.10 Million CN¥16.43 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow